Thales / M. Ehrenshaft A. E. / J. Wilson L. C. / Brazil 3 Laboratory / PPT5 / Creative Commons / PPHME / A. Nzila S. A. / A. Bhattarai A. S. / Hindawi Publishing Corporation / /
Country
Germany / Switzerland / United States / Brazil / / /
Facility
Heart Institute / University of S˜ao Paulo / Institute of Biomedical Science / S˜ao Paulo State University / Laboratory of Genetics / /
IndustryTerm
active site / antioxidant systems / treatment of malaria / treatment of epilepsy / Chemical structures / chemical / malaria treatment / /
Department of Parasitology / Multi User Center for Biomolecular Innovation / World Health Organization / Department of Physics / National Academy of Sciences / S˜ao Paulo State University / Heart Institute / Institute of Biomedical Science / BioMed Research International Academy of Sciences of the United States of America / Unit for Drug Discovery / University of S˜ao Paulo / /
Person
Carsten Wrenger / Eneas de Carvalho Aguiar / R. Gujjar / Lineu Prestes / Jasmin Lindner / Ashley M. Buckle / /
Position
Prime Minister / Academic Editor / Representative / Professor / J. H. Hunter / /
Product
glycine / /
ProvinceOrState
New York / Zanzibar / /
PublishedMedium
Current Opinion / Biochemical Journal / Journal of Clinical Investigation / PLoS Medicine / the National / Journal of Molecular Biology / Antimicrobial Agents and Chemotherapy / Journal of Bacteriology / Proceedings of the National Academy of Sciences / PLoS ONE / Nature Medicine / Molecular Biology / /
TVStation
Kyle / /
Technology
alpha / cloning / Drug Discovery / DNA synthesis / rational drug design / chemotherapy / molecular evolution / /
Vitamin B6-Dependent Enzymes in the Human Malaria Parasite Plasmodium falciparum: A Druggable Target?